|
|
|
市場調查報告書
生物晶片市場（DNA微陣列、實驗室晶片、蛋白質微陣列、組織・細胞陣列）動向以及世界的預測（2010∼2015年）
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
|
生物晶片市場（DNA微陣列、實驗室晶片、蛋白質微陣列、組織・細胞陣列）動向以及世界的預測（2010∼2015年） 是由出版商Markets and Markets在2011年08月所出版的。
這份英文市場調查報告書包含278 Pages 價格從美金4650起跳。
全球生物晶片市場在2010年達26億美元規模，預估2015年將有56億美元。癌症診斷與發現資料建立的應用擴張與個別化醫療的普及、政府投資等因素推進了成長。
本報告書為全球生物晶片市場之相關應用、種類、各地區分析、各子市場收益預測與動向等整理，概述如下
第1章 導論
第2章 總綱
第3章 市場概要
- 導論
- 課題
- 必須事項
- 市場動向
- 市場分類
- 莫觀使用者分析
- 市場佔有率分析
- DNA微陣列市場
- LOC／微流體市場
- 蛋白質微陣列市場
第4章 全球DNA微陣列市場
- 導論
- 各用途DNA微陣列市場
- 基因發現
- SNP機因型
- 癌診斷與治療
- 基因組學
- 農業用生物科技
- 創藥
- 其他
第5章 全球實驗式晶片／微流體市場
- 導論
- 各用途實驗室晶片／微流體市場
- 高通量監測
- 基因組學
- 蛋白質組學
- 創藥
- IVD與POC
- 診斷
- 其他
第6章 全球蛋白質微陣列市場
- 導論
- 種類別蛋白質微陣列市場
- 發現蛋白質微
- 機能性蛋白質微陣列陣列
- 逆相蛋白質微陣列陣列
- 各用途蛋白質微陣列陣列
- 發現檔案收集
- 蛋白質組學
- 高通量監測
- 診斷
- 創藥
- 其他
第7章 全球其他陣列市場
- 各種類其他陣列市場
- 其他各用途陣列市場
- 發現資料建立
- 癌診斷
- 毒性基因組學
- 基因組學
- 創藥
- 其他
第8章 全球各地區生物晶片市場
第9章 競爭情勢
第10章 企業檔案
圖表
Abstract
Report Description
A biochip is defined as a collection of miniaturized test sites (microarrays)
arranged on a solid platform that allows multiple tests to be performed at the
same time with increased efficiency and higher speed. The global biochip
market is studied by the types and key applications. It was valued at $2.6
billion in 2010 and is expected to reach $5.6 billion by 2015; growing at a
CAGR of 16.7%. This growth is attributed to increasing applications in cancer
diagnostics and expression profiling, the boom in personalized medicine, and
government funding.
DNA microarrays represent the largest segment of this market and will continue
to be the largest contributor during the study period (2010-2015). However,
this segment will be closely followed by lab-on-chip (LOC) in the coming years
due to its wide applications and increased adoption by various biotechnology,
pharmaceutical companies, and research laboratories. The third largest segment
- protein microarrays will be the fastest growing segment; forecasted to grow
at a CAGR of 19.9% during the study period due to advances in the fields of
genomics and proteomics and improvements in the field of recombinant proteins.
Reverse phase protein microarrays designed for targeted therapies in cancer
holds promise in the global biochip market in the next 5-10 years. These
microarrays provide increased accuracy and enhanced efficacy for the detection
of rare molecules as compared to existing microarray surfaces for cancer
research & diagnosis to help understand the proteins in tumor cells. Thus,
they have helped open the avenues for personalized methods for cancer therapy.
The market of Asia will account for a bulk of the future biochip market growth
due to its high growth potential and huge demand from emerging economies such
as India and China - the large pool of heterogeneous patient population, and
increasing R&D investment in these countries. The top players in the biochip
market such as Affymetrix, Inc., Illumina, Inc., and Fluidigm Corporation have
relocated their manufacturing base to Singapore to take advantage of the
benefits the country offers; coupled with rising demand from neighboring
countries of Asia. The players also benefit from a well-established
semiconductor manufacturing base including chip technologies. Singapore has
made focused efforts to attract life sciences corporates with dedicated
investments accounting for 3% of the country' s GDP. It came up with its R&D
center - Singapore' s Biopolis R&D center in 2003-2004 and is home to the
Genome Institute of Singapore.
Scope of the report
This research report categorizes the global biochips market on the basis of
applications, types, and geography; forecasting revenues and analyzing trends
in each of the following submarkets:
On the basis of applications:
- DNA applications: Gene expression, SNP genotyping, cancer diagnosis
& treatment, genomics, agricultural biotechnology, drug discovery, and others.
- Lab on chip applications: Drug discovery, genomics, diagnostics,
proteomics, IVD & POC, high throughput screening, and others.
- Protein microarray applications: Expression profiling, proteomics,
high throughput screening, diagnostics, drug discovery, and others.
- Other array applications: Expression profiling, cancer diagnostics,
toxicogenomics, genomics, drug discovery, and others.
On the basis of types:
DNA microarrays, lab on chip, protein microarrays, other arrays (cell arrays
and tissue arrays)
On the basis of geography:
North America, Europe, Asia, and Rest of the World.
Each section will provide market data, market drivers, trends and
opportunities, top-selling products, key players, and competitive outlook. It
will also provide market tables for covering the sub-segments. In addition,
the report will throw light on more than 20 company profiles covering all the
sub-segments.
Summary
The global biochips market is segmented into DNA microarrays, protein
microarrays (expressional, functional, and reverse), lab-on-chip (LOC), and
other arrays that include cell array and tissue array (frozen array and
formalin fixed paraffin embedded array). The global biochip market is studied
by the types and key applications. It was valued at $2.6 billion in 2010 and
is expected to reach $5.6 billion by 2015; growing at a CAGR of 16.7%. DNA
microarray is the largest contributing segment of the biochip family; followed
by lab-on-chip, protein microarrays.
The biochip market is influenced by its parent (biotechnology) market with
North America and Europe accounting for a larger chunk in the red sector
(human health) of the biotech market and the economies of Asia more focused
towards the green sector (agricultural and zoo-technical sector).
The global biochip market is primarily driven by growth in personalized
medicine, government funding, technical advancements, and cancer diagnosis.
Cancer ranks second after cardiovascular diseases in terms of the number of
deaths per year globally and several biochip initiatives are also directed
towards fast cancer detection and therapy.
Cross border collaboration across most of the biotech companies has spurred
the growth of the biochip market in the Asian subcontinent. Private equity
firms and venture capitalists are investing more in countries such as India,
China, and Singapore for new opportunities. The government in these countries
has planned substantial budget allocations for developing the biotechnology
sector. The major biochip players are moving east to take advantage of the
growth opportunities. Singapore is the most preferred locations to set up
manufacturing facilities for biotechnology and pharmaceutical companies
considering its technical knowledge, resources, and infrastructure. Leading
players in the biochip market such as Affymetrix Inc., Fluidigm, and Illumina
had set up their manufacturing facilities in Singapore to take advantage of
the growing demand and gain competitive edge with large number of regional
players
Table of Contents
1 INTRODUCTION
- 1.1 KEY TAKE-AWAYS
- 1.2 REPORT DESCRIPTION
- 1.3 MARKETS COVERED
- 1.4 STAKEHOLDERS
- 1.5 RESEARCH METHODOLOGY
- 1.5.1 MARKET SIZE
- 1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES
- 1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES
- 1.5.4 MARKET SHARE
- 1.5.5 ASSUMPTIONS MADE FOR THE REPORT
2 EXECUTIVE SUMMARY
- 2.1 OVERVIEW OF THE MARKET
- 2.2 KEY FINDINGS
- 2.3 RECOMMENDATIONS
- 2.3.1 APPLICATION OF REVERSE PHASE PROTEIN MICROARRAYS IN CANCER
DIAGNOSIS IS A LUCRATIVE INVESTMENT OPTION
3 MARKET OVERVIEW
- 3.1 INTRODUCTION
- 3.2 BURNING ISSUE
- 3.2.1 EMERGENCE OF NEW DISEASES & DISEASE COMPLEXITY CATALYZE ADOPTION
OF BIOCHIPS IN DIAGNOSTICS
- 3.3 WINNING IMPERATIVES
- 3.3.1 STANDARDIZATION IS A NECESSITY
- 3.3.2 COST
- 3.3.3 NEED OF CROSS COMPATIBILITY
- 3.3.4 END-TO-END SOLUTIONS
- 3.4 MARKET DYNAMICS
- 3.4.1 DRIVERS
- 3.4.1.1 Growth in personalized medicine
- 3.4.1.2 Increase Government funding
- 3.4.1.3 Cancer diagnosis & treatment is on a rise
- 3.4.1.4 Technical advances
- 3.4.2 RESTRAINTS
- 3.4.2.1 Knowledge constraints with respect to technical know-how
- 3.4.2.2 Lack of healthcare coverage restricts the adoption
- 3.4.3 OPPORTUNITIES
- 3.4.3.1 Growth of market in the sub-continent of Asia
- 3.4.3.2 Widening applications market
- 3.4.4 TRENDS
- 3.4.4.1 Robust deals & alliances
- 3.4.4.2 Relocating manufacturing facilities to gain competitive edge
- 3.4.4.2.1 Advantage Singapore
- 3.4.4.3 Next generation technology for LOC
- 3.4.4.3.1 Lab on CD-ROM
- 3.4.4.3.2 EFAD chip technology
- 3.4.4.4 Outsourcing of the biochip technology
- 3.4.4.4.1 Reduction in the labor cost
- 3.4.4.4.2 Increased focus on core business
- 3.4.4.4.3 Risk reduction
- 3.4.4.4.4 Utilization of business expertise
- 3.4.4.4.5 Reduction in capital expenditure
- 3.5 MARKET BREAKDOWN
- 3.6 END-USER ANALYSIS
- 3.7 MARKET SHARE ANALYSIS
- 3.7.1 DNA MICROARRAY MARKET SHARE ANALYSIS
- 3.7.2 LOC/MICROFLUIDICS MARKET SHARE ANALYSIS
- 3.7.3 PROTEIN MICROARRAY MARKET SHARE ANALYSIS
4 GLOBAL DNA MICROARRAY MARKET
- 4.1 INTRODUCTION
- 4.2 DNA MICROARRAY MARKET, BY APPLICATIONS
- 4.2.1 GENE EXPRESSION
- 4.2.2 SNP GENOTYPING
- 4.2.3 CANCER DIAGNOSIS & TREATMENT
- 4.2.4 GENOMICS
- 4.2.5 AGRICULTURAL BIOTECHNOLOGY
- 4.2.6 DRUG DISCOVERY
- 4.2.7 OTHERS
5 GLOBAL LAB-ON-CHIP/MICROFLUIDICS MARKET
- 5.1 INTRODUCTION
- 5.2 LOC/MICROFLUIDICS MARKET, BY APPLICATIONS
- 5.2.1 HIGH THROUGHPUT SCREENING
- 5.2.2 GENOMICS
- 5.2.3 PROTEOMICS
- 5.2.4 DRUG DISCOVERY
- 5.2.5 IVD & POC
- 5.2.6 DIAGNOSTICS
- 5.2.7 OTHERS
6 GLOBAL PROTEIN MICROARRAY MARKET
- 6.1 INTRODUCTION
- 6.2 PROTEIN MICROARRAY MARKET, BY TYPES
- 6.2.1 EXPRESSIONAL PROTEIN MICROARRAY
- 6.2.2 FUNCTIONAL PROTEIN MICROARRAY
- 6.2.3 REVERSE PHASE PROTEIN MICROARRAY
- 6.3 PROTEIN MICROARRAY MARKET, BY APPLICATIONS
- 6.3.1 EXPRESSION PROFILING
- 6.3.2 PROTEOMICS
- 6.3.3 HIGH THROUGHPUT SCREENING
- 6.3.4 DIAGNOSTICS
- 6.3.5 DRUG DISCOVERY
- 6.3.6 OTHERS
7 GLOBAL OTHER ARRAYS MARKET
- 7.1 OTHER ARRAYS MARKET, BY TYPES
- 7.1.1 CELL ARRAY
- 7.1.2 TISSUE ARRAY
- 7.1.2.1 FFPE Arrays
- 7.1.2.2 Frozen Arrays
- 7.2 OTHER ARRAYS MARKET, BY APPLICATIONS
- 7.2.1 EXPRESSION PROFILING
- 7.2.2 CANCER DIAGNOSTICS
- 7.2.3 TOXICOGENOMICS
- 7.2.4 GENOMICS
- 7.2.5 DRUG DISCOVERY
- 7.2.6 OTHERS
8 GLOBAL BIOCHIP MARKET, BY GEOGRAPHY
- 8.1 INTRODUCTION
- 8.2 NORTH AMERICA
- 8.3 EUROPE
- 8.4 ASIA
- 8.5 ROW
9 COMPETITIVE LANDSCAPE
10 COMPANY PROFILES
- 10.1 AFFYMETRIX INC
- 10.1.1 OVERVIEW
- 10.1.2 FINANCIALS
- 10.1.3 PRODUCTS & SERVICES
- 10.1.4 STRATEGY
- 10.1.5 DEVELOPMENTS
- 10.2 AGILENT TECHNOLOGIES INC
- 10.2.1 OVERVIEW
- 10.2.2 FINANCIALS
- 10.2.3 PRODUCTS & SERVICES
- 10.2.4 STRATEGY
- 10.2.5 DEVELOPMENTS
- 10.3 BIOCHAIN INSTITUTE INC
- 10.3.1 OVERVIEW
- 10.3.2 FINANCIALS
- 10.3.3 PRODUCTS & SERVICES
- 10.3.4 STRATEGY
- 10.3.5 DEVELOPMENTS
- 10.4 BIOMERIEUX SA
- 10.4.1 OVERVIEW
- 10.4.2 FINANCIALS
- 10.4.3 PRODUCTS & SERVICES
- 10.4.4 STRATEGY
- 10.4.5 DEVELOPMENTS
- 10.5 BIO-RAD LABORATORIES INC
- 10.5.1 OVERVIEW
- 10.5.2 FINANCIALS
- 10.5.3 PRODUCTS & SERVICES
- 10.5.4 STRATEGY
- 10.5.5 DEVELOPMENTS
- 10.6 CALIPER LIFE SCIENCES INC
- 10.6.1 OVERVIEW
- 10.6.2 FINANCIALS
- 10.6.3 PRODUCTS & SERVICES
- 10.6.4 STRATEGY
- 10.6.5 DEVELOPMENTS
- 10.7 CEPHEID INC
- 10.7.1 OVERVIEW
- 10.7.2 FINANCIALS
- 10.7.3 PRODUCTS & SERVICES
- 10.7.4 STRATEGY
- 10.7.5 DEVELOPMENTS
- 10.8 CYBRDI INC
- 10.8.1 OVERVIEW
- 10.8.2 FINANCIALS
- 10.8.3 PRODUCTS & SERVICES
- 10.8.4 STRATEGY
- 10.8.5 DEVELOPMENTS
- 10.9 EMD MILLIPORE
- 10.9.1 OVERVIEW
- 10.9.2 FINANCIALS
- 10.9.3 PRODUCTS & SERVICES
- 10.9.4 STRATEGY
- 10.9.5 DEVELOPMENTS
- 10.10 FLUIDIGM CORP
- 10.10.1 OVERVIEW
- 10.10.2 FINANCIALS
- 10.10.3 PRODUCTS & SERVICES
- 10.10.4 STRATEGY
- 10.10.5 DEVELOPMENTS
- 10.11 GAMIDA FOR LIFE GROUP
- 10.11.1 OVERVIEW
- 10.11.2 FINANCIALS
- 10.11.3 PRODUCTS & SERVICES
- 10.11.4 STRATEGY
- 10.11.5 DEVELOPMENTS
- 10.12 ILLUMINA INC
- 10.12.1 OVERVIEW
- 10.12.2 FINANCIALS
- 10.12.3 PRODUCTS & SERVICES
- 10.12.4 STRATEGY
- 10.12.5 DEVELOPMENTS
- 10.13 LIFE TECHNOLOGIES CORP
- 10.13.1 OVERVIEW
- 10.13.2 FINANCIALS
- 10.13.3 PRODUCTS & SERVICES
- 10.13.4 STRATEGY
- 10.13.5 DEVELOPMENTS
- 10.14 ORIGENE TECHNOLOGIES INC
- 10.14.1 OVERVIEW
- 10.14.2 FINANCIALS
- 10.14.3 PRODUCTS & SERVICES
- 10.14.4 STRATEGY
- 10.14.5 DEVELOPMENTS
- 10.15 PERKINELMER INC
- 10.15.1 OVERVIEW
- 10.15.2 FINANCIALS
- 10.15.3 PRODUCTS & SERVICES
- 10.15.4 STRATEGY
- 10.15.5 DEVELOPMENTS
- 10.16 ROCHE NIMBLEGEN INC
- 10.16.1 OVERVIEW
- 10.16.2 FINANCIALS
- 10.16.3 PRODUCTS & SERVICES
- 10.16.4 STRATEGY
- 10.16.5 DEVELOPMENTS
- 10.17 SEQUENOM
- 10.17.1 OVERVIEW
- 10.17.2 FINANCIALS
- 10.17.3 PRODUCTS & SERVICES
- 10.17.4 STRATEGY
- 10.17.5 DEVELOPMENTS
- 10.18 SIGMA ALDRICH CORP
- 10.18.1 OVERVIEW
- 10.18.2 FINANCIALS
- 10.18.3 PRODUCTS & SERVICES
- 10.18.4 STRATEGY
- 10.18.5 DEVELOPMENTS
- 10.19 OTHERS
- 10.19.1 IMGENEX
- 10.19.1.1 Overview
- 10.19.1.2 Financials
- 10.19.1.3 Products & services
- 10.19.2 ISU ABXIS CO. LTD
- 10.19.2.1 Overview
- 10.19.2.2 Financials
- 10.19.2.3 Products & services
- 10.19.3 US BIOMAX INC
- 10.19.3.1 Overview
- 10.19.3.2 Financials
- 10.19.3.3 Products & services
LIST OF TABLES
- TABLE 1 GLOBAL BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)
- TABLE 2 LIFE EXPECTANCY AT BIRTH
- TABLE 3 TAX ENVIRONMENT
- TABLE 4 TAX ENVIRONMENT: FOR NEW START UP COMPANIES IN SINGAPORE
- TABLE 5 DNA MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 6 TOP FIVE DNA MICROARRAY TECHNOLOGIES
- TABLE 7 COMPARISON BETWEEN PHOTOLITHOGRAPHY & INKJET TECHNOLOGY
- TABLE 8 GLOBAL DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 9 DNA MICROARRAY: GENE EXPRESSION MARKET REVENUE, BY GEOGRAPHY, 2008
- 2015 ($MILLION)
- TABLE 10 DNA MICROARRAY: SNP GENOTYPING MARKET REVENUE, BY GEOGRAPHY, 2008
- 2015 ($MILLION)
- TABLE 11 DNA MICROARRAY: CANCER DIAGNOSIS & TREATMENT MARKET REVENUE, BY
GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 12 DNA MICROARRAY: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 -
2015 ($MILLION)
- TABLE 13 DNA MICROARRAY: AGRICULTURAL BIOTECHNOLOGY MARKET REVENUE, BY
GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 14 DNA MICROARRAY: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008
- 2015 ($MILLION)
- TABLE 15 DNA MICROARRAY: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 16 LOC MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 17 GLOBAL LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)
- TABLE 18 COMPARATIVE ANALYSIS OF MICROFLUIDIC ASSAY TECHNIQUES
- TABLE 19 LOC: HTS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 20 LOC: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 21 LOC: PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 22 LOC: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 23 LOC: IVD & POC MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 24 LOC: DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 25 LOC: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 26 PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 27 PROTEIN MICROARRAY MANUFACTURING TECHNOLOGIES
- TABLE 28 GLOBAL PROTEIN MICROARRAY MARKET REVENUE, BY TYPES, 2008 - 2015
($MILLION)
- TABLE 29 EXPRESSIONAL PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY,
2008 - 2015 ($MILLION)
- TABLE 30 FUNCTIONAL PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008
- 2015 ($MILLION)
- TABLE 31 REVERSE PHASE PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY,
2008 - 2015 ($MILLION)
- TABLE 32 GLOBAL PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 -
2015 ($MILLION)
- TABLE 33 PROTEIN MICROARRAY APPLICATIONS IN EXPRESSION PROFILING
- TABLE 34 PROTEIN MICROARRAY: EXPRESSION PROFILING MARKET REVENUE, BY
GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 35 PROTEIN MICROARRAY APPLICATIONS IN PROTEOMICS
- TABLE 36 PROTEIN MICROARRAY: PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008
- 2015 ($MILLION)
- TABLE 37 PROTEIN MICROARRAY: HTS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 38 PROTEIN MICROARRAY: DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY,
2008 - 2015 ($MILLION)
- TABLE 39 PROTEIN MICROARRAY: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY,
2008 - 2015 ($MILLION)
- TABLE 40 PROTEIN MICROARRAY: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 -
2015 ($MILLION)
- TABLE 41 GLOBAL OTHER ARRAYS MARKET REVENUE, BY TYPES, 2008 - 2015
($MILLION)
- TABLE 42 OTHER ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 43 CELL ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 44 GLOBAL TISSUE ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 45 TISSUE ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 46 FFPE ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 47 FROZEN ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 48 GLOBAL OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 49 OTHER ARRAYS: EXPRESSION PROFILING MARKET REVENUE, BY GEOGRAPHY,
2008 - 2015 ($MILLION)
- TABLE 50 OTHER ARRAYS: CANCER DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY,
2008 - 2015 ($MILLION)
- TABLE 51 OTHER ARRAYS: TOXICOGENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 -
2015 ($MILLION)
- TABLE 52 OTHER ARRAYS: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 53 OTHER ARRAYS: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 -
2015 ($MILLION)
- TABLE 54 OTHER ARRAYS: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015
($MILLION)
- TABLE 55 BIOCHIP MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)
- TABLE 56 NORTH AMERICA: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 57 NORTH AMERICA: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS,
2008 - 2015 ($MILLION)
- TABLE 58 NORTH AMERICA: PROTEIN MICROARRAY MARKET REVENUE,BY PRODUCTS,
2008 - 2015 ($MILLION)
- TABLE 59 NORTH AMERICA: PROTEIN MICROARRAY MARKET REVENUE, BY
APPLICATIONS, 2008 - 2015 ($MILLION)
- TABLE 60 NORTH AMERICA: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 61 NORTH AMERICA: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 -
2015 ($MILLION)
- TABLE 62 NORTH AMERICA: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008
- 2015 ($MILLION)
- TABLE 63 EUROPE: BIOCHIP MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 -
2015 ($MILLION)
- TABLE 64 EUROPE: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 -
2015 ($MILLION)
- TABLE 65 EUROPE: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 -
2015 ($MILLION)
- TABLE 66 EUROPE: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008
- 2015 ($MILLION)
- TABLE 67 EUROPE: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 68 EUROPE: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 69 EUROPE: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 70 ASIA: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)
- TABLE 71 ASIA: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 72 ASIA: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 73 ASIA: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 -
2015 ($MILLION)
- TABLE 74 ASIA: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)
- TABLE 75 ASIA: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 76 ASIA: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 77 ROW: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)
- TABLE 78 ROW: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 79 ROW: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 80 ROW: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 -
2015 ($MILLION)
- TABLE 81 ROW: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)
- TABLE 82 ROW: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015
($MILLION)
- TABLE 83 ROW: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015
($MILLION)
- TABLE 84 NEW PRODUCT LAUNCHES
- TABLE 85 AGREEMENTS & COLLABORATIONS
- TABLE 86 MERGERS & ACQUISITIONS
- TABLE 87 AFFYMETRIX INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($MILLION)
- TABLE 88 AFFYMETRIX INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($MILLION)
- TABLE 89 AFFYMETRIX INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
- TABLE 90 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($MILLION)
- TABLE 91 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($MILLION)
- TABLE 92 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010
($MILLION)
- TABLE 93 BIOMERIEUX SA: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($MILLION)
- TABLE 94 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($MILLION)
- TABLE 95 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010
($MILLION)
- TABLE 96 BIO-RAD LABORATORIES: MARKET REVENUE, BY GEOGRAPHY, 2008 - 2010
($MILLION)
- TABLE 97 CALIPER LIFE SCIENCES INC: TOTAL REVENUE AND R&D EXPENSES, 2008 -
2010 ($THOUSAND)
- TABLE 98 CALIPER LIFE SCIENCES INC:TOTAL REVENUE, BY GEOGRAPHY, 2008 -
2010 ($THOUSAND)
- TABLE 99 CALIPER LIFE SCIENCES INC: TOTAL REVENUE, BY SEGMENTS, 2009 -
2010 ($THOUSAND)
- TABLE 100 CEPHEID INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($THOUSAND)
- TABLE 101 CEPHEID: TOTAL PRODUCT REVENUE, BY GEOGRAPHY, 2008 - 2010
($THOUSAND)
- TABLE 102 CEPHEID: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)
- TABLE 103 CEPHEID: TOTAL REVENUE, BY SUB-SEGMENTS, 2008 - 2010 ($THOUSAND)
- TABLE 104 CYBRDI INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2010
($THOUSAND)
- TABLE 105 CYBRDI INC: TOTAL REVENUE, BY COUNTRY, 2009 - 2010 ($THOUSAND)
- TABLE 106 CYBRDI INC: TOTAL REVENUE, BY SEGMENTS ($THOUSAND)
- TABLE 107 FLUIDIGM CORP: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($THOUSAND)
- TABLE 108 FLUIDIGM CORP: TOTAL PRODUCTS REVENUE, BY GEOGRAPHY, 2008 - 2010
($THOUSAND)
- TABLE 109 FLUIDIGM CORP: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010
($THOUSAND)
- TABLE 110 ILLUMINA INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($THOUSAND)
- TABLE 111 ILLUMINA INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($THOUSAND)
- TABLE 112 ILLUMINA INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)
- TABLE 113 LIFE TECHNOLOGIES CORP: TOTAL REVENUE AND R&D EXPENSES, 2008 -
2010 ($MILLION)
- TABLE 114 LIFE TECHNOLOGIES CORP: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($THOUSAND)
- TABLE 115 LIFE TECHNOLOGIES CORP: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010
($MILLION)
- TABLE 116 PERKINELMER INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($MILLION)
- TABLE 117 PERKINELMER INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($MILLION)
- TABLE 118 PERKINELMER INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010
($MILLION)
- TABLE 119 SEQUENOM INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($THOUSAND)
- TABLE 120 SEQUENOM INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($THOUSAND)
- TABLE 121 SEQUENOM INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)
- TABLE 122 SIGMA-ALDRICH: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($MILLION)
- TABLE 123 SIGMA-ALDRICH: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010
($MILLION)
- TABLE 124 SIGMA-ALDRICH: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
- TABLE 125 ISU ABXIS CO. LTD: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010
($THOUSAND)
LIST OF FIGURES
- FIGURE 1 BIOCHIP MARKET SEGMENTATION
- FIGURE 2 GLOBAL BIOCHIP MARKET, 2010 VS 2015
- FIGURE 3 MARKET COMPOSITION, 2010
- FIGURE 4 COMPOSITION OF END-USERS, 2010
- FIGURE 5 DNA MICROARRAY MARKET SHARE ANALYSIS, BY COMPANIES, 2010
- FIGURE 6 GLOBAL LAB-ON-CHIP MARKET SHARE ANALYSIS, BY COMPANIES, 2010
- FIGURE 7 GLOBAL PROTEIN MICROARRAY MARKET SHARE ANALYSIS, BY COMPANIES,
2010
- FIGURE 8 DNA MICROARRAY MARKET - APPLICATIONS MARKET SEGMENTATION
- FIGURE 9 LAB-ON-CHIP APPLICATIONS MARKET SEGMENTATION
- FIGURE 10 APPLICATION OF LAB-ON-CHIP TECHNOLOGY IN DRUG DISCOVERY
- FIGURE 11 PROTEIN MICROARRAY APPLICATIONS MARKET SEGMENTATION
- FIGURE 12 KEY GROWTH STRATEGIES, JANUARY 2008 - JUNE 2011
|
 |
